ORNL's Communications team works with news media seeking information about the laboratory. Media may use the resources listed below or send questions to news@ornl.gov.
1 - 10 of 15 Results
In fall 2020, Kairos Power selected Oak Ridge, Tennessee, to build its advanced nuclear reactor due to the area's strong nuclear expertise and infrastructure. This project, along with other new nuclear ventures like Ultra Safe Nuclear and Type One Energy, highlights a growing trend of nuclear industry resurgence in East Tennessee, supported by local and state investments aiming to make the region a major nuclear technology hub.
The Department of Energy’s Oak Ridge National Laboratory is collaborating with industry on six new projects focused on advancing commercial nuclear energy technologies that offer potential improvements to current nuclear reactors and move new reactor designs closer to deployment.
Scientists from Oak Ridge National Laboratory performed a corrosion test in a neutron radiation field to support the continued development of molten salt reactors.
With an organ-on-a-chip technology, scientists at Oak Ridge National Laboratory are testing the effects of radiation on cells that mimic human respiration.
The United Kingdom’s National Nuclear Laboratory and the U.S. Department of Energy’s Oak Ridge National Laboratory have agreed to cooperate on a wide range of nuclear energy research and development efforts that leverage both organizations’ unique expertise and capabilities.
Experts focused on the future of nuclear technology will gather at Oak Ridge National Laboratory for the fourth annual Molten Salt Reactor Workshop on October 3–4.
The Consortium for Advanced Simulation of Light Water Reactors at the Department of Energy’s Oak Ridge National Laboratory has named David J. Kropaczek its director.
A tiny vial of gray powder produced at the Department of Energy’s Oak Ridge National Laboratory is the backbone of a new experiment to study the intense magnetic fields created in nuclear collisions.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.